IFP Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6K | Buy |
2,012
+10
| +0.5% | +$92 | ﹤0.01% | 2590 |
|
|
2025
Q1 | $17.2K | Sell |
2,002
-35
| -2% | -$300 | ﹤0.01% | 2355 |
|
|
2024
Q4 | $21.9K | Buy |
2,037
+37
| +2% | +$397 | ﹤0.01% | 2208 |
|
|
2024
Q3 | $11.4K | Hold |
2,000
| – | – | ﹤0.01% | 2373 |
|
|
2024
Q2 | $8.44K | Hold |
2,000
| – | – | ﹤0.01% | 2399 |
|
|
2024
Q1 | $10.2K | Hold |
2,000
| – | – | ﹤0.01% | 2228 |
|
|
2023
Q4 | $18.6K | Hold |
2,000
| – | – | ﹤0.01% | 1947 |
|
|
2023
Q3 | $13.1K | Hold |
2,000
| – | – | ﹤0.01% | 2148 |
|
|
2023
Q2 | $16.3K | Hold |
2,000
| – | – | ﹤0.01% | 2109 |
|
|
2023
Q1 | $2.9K | Sell |
2,000
-1,000
| -33% | -$1.45K | ﹤0.01% | 2774 |
|
|
2022
Q4 | $4K | Sell |
3,000
-1,000
| -25% | -$1.33K | ﹤0.01% | 3853 |
|
|
2022
Q3 | $5K | Hold |
4,000
| – | – | ﹤0.01% | 3996 |
|
|
2022
Q2 | $5K | Hold |
4,000
| – | – | ﹤0.01% | 3751 |
|
|
2022
Q1 | $5K | Buy |
4,000
+2,000
| +100% | +$2.5K | ﹤0.01% | 3751 |
|
|
2021
Q4 | $35K | Hold |
2,000
| – | – | ﹤0.01% | 1658 |
|
|
2021
Q3 | $36K | Hold |
2,000
| – | – | ﹤0.01% | 1661 |
|
|
2021
Q2 | $46K | Hold |
2,000
| – | – | ﹤0.01% | 1565 |
|
|
2021
Q1 | $30K | Sell |
2,000
-2,000
| -50% | -$30K | ﹤0.01% | 1654 |
|
|
2020
Q4 | $22K | Hold |
4,000
| – | – | ﹤0.01% | 1749 |
|
|
2020
Q3 | $18K | Hold |
4,000
| – | – | ﹤0.01% | 1682 |
|
|
2020
Q2 | $20K | Hold |
4,000
| – | – | ﹤0.01% | 1560 |
|
|
2020
Q1 | $12K | Buy |
+4,000
| New | +$12K | ﹤0.01% | 1675 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2863 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3079 |
|